Conference Coverage

00:03:15

Investigating Alpha-Beta Cell Proximity and T-Cell...

Conference Coverage ·

2026/10/02

Guest: Vira Kravets, PhD Cellular interactions within pancreatic islets may provide important insights into the early stages and pathogenesis of type 1 diabetes (T1D). Tune in to hear Dr. Vira Kravets share research she presented at the 2026 European Association for the Study of Diabetes Annual Meeting, which focused on how alpha-beta cell proximity influences GLP-1R-mediated communication as well as the spatial association between alpha cells and T cells in human islets. Dr. Kravets

en

00:03:15

Unanswered Questions in T1D: What Immunology and...

Conference Coverage ·

2026/10/02

Guest: Edward Phelps, PhD Despite advances in type 1 diabetes (T1D) research, key questions remain about disease progression, immune mechanisms, and the optimal timing of intervention. Here to explore how immunology and islet research could help address these knowledge gaps is Dr. Edward Phelps. He’s an Associate Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida.

en

00:03:30

Investigating Beta Cell Dysfunction and Immune...

Conference Coverage ·

2026/10/02

Guest: Edward Phelps, PhD Residual beta cells may persist after a type 1 diabetes (T1D) diagnosis, but how well do they continue to function? Tune in to hear Dr. Edward Phelps discuss research he presented at the 2026 European Association for the Study of Diabetes Annual Meeting that examined glucose-stimulated calcium responses in living pancreatic tissue from donors with recent-onset T1D. He explains how residual beta cells showed impaired responses to glucose regardless of the local

en

00:03:15

Enhancing the Metabolic Benefits of GLP-1s with Diet...

Conference Coverage ·

2026/10/02

Guest: Laura Chiavaroli, PhD How might diet and exercise influence metabolic outcomes among patients taking GLP-1 medicines? To find out, we recently spoke with Dr. Laura Chiavaroli, who discussed this topic at the 2026 European Association for the Study of Diabetes Annual Meeting. She shares emerging evidence on combining lifestyle interventions with GLP-1 therapy and highlights where gaps in research still remain. Dr. Chiavaroli is an Assistant Professor in the Department of

en

00:04:00

Tobacco-Related Stigma as a Barrier to Lung Cancer...

Conference Coverage ·

2026/09/18

Guest: Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM For patients who smoke or have a history of smoking, seeking lung cancer screening can mean confronting more than the fear of a diagnosis; it can also mean anticipating blame and judgment. Dr. Lisa Carter-Bawa joins us to share how tobacco-related stigma and nihilism can discourage screening, honest conversations, and follow-up care. Learn how approaching patients with greater awareness and compassion can help create a more

en

00:04:45

A Patient-First Approach to Smoking Cessation and...

Conference Coverage ·

2026/09/18

Guest: Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM Even well-intentioned conversations about tobacco use can leave patients feeling judged and potentially less willing to engage in lung cancer screening, follow-up, or cessation support. Tune in as Dr. Lisa Carter-Bawa shares practical strategies for fostering more supportive, patient-centered conversations that reduce stigma and keep the door open to screening and continued care. In addition to being the Director of the Cancer

en

00:02:45

Key Questions Shaping Chemotherapy-Free Treatment in...

Conference Coverage ·

2026/09/09

Guest: Jonathon B. Cohen, MD, MS As chemotherapy-free approaches for mantle cell lymphoma continue to evolve, important questions remain about how best to incorporate them into clinical practice. Here to help shed light on the key unknowns surrounding patient selection, treatment sequencing, and the potential implications of using targeted and immune therapies in the frontline setting is Dr. Jonathon Cohen. He’s a board-certified hematologist and medical oncologist at Emory Winship

en

00:02:30

Making the Most of WCLC 2026: A Guide for...

Conference Coverage ·

2026/09/04

Guest: Triparna Sen, PhD The 2026 World Conference on Lung Cancer (WCLC) is bringing together leaders, emerging investigators, and educational opportunities from across the lung cancer field. Dr. Triparna Sen sat down with us to share her perspective on how early-career clinicians and researchers can get the most out of their WCLC experience. She's the Max Morehouse Endowed Chair in Cancer Research and Associate Director of Research for the Division of Medical Oncology at The Ohio

en

00:04:45

Resistance and Transformation in EGFR-Mutant Lung Cancer

Conference Coverage ·

2026/09/04

Guest: Triparna Sen, PhD How does the immune microenvironment change as EGFR-mutant lung adenocarcinoma develops treatment resistance and undergoes histologic transformation? In a recent study, multiomic spatial findings revealed broad immune suppression following transformation, including changes in T cells and immunosuppressive macrophages. Learn more with Dr. Triparna Sen, who shared these new findings at the 2026 World Conference on Lung Cancer. She's the Max Morehouse Endowed

en

00:03:15

A Look at WCLC 2026: Pivotal Trials and Emerging...

Conference Coverage ·

2026/09/04

Guest: Triparna Sen, PhD The 2026 World Conference on Lung Cancer (WCLC) is set to spotlight pivotal research that could inform the next chapter of lung cancer care. Dr. Triparna Sen previews key phase III trials across small cell and non-small cell lung cancer, including emerging data on antibody-drug conjugates, targeted therapies, MRI surveillance, and adjuvant treatment, as well as sessions focused on biomarkers and liquid biopsy. Dr. Sen is the Max Morehouse Endowed Chair in

en

00:05:00

Exploring AI-Powered ATTR-CM Detection

Conference Coverage ·

2026/09/03

Guest: Bruno Batinica, MD Earlier recognition of ATTR-CM remains a challenge, but emerging applications of AI could offer a new way to raise clinical suspicion. Dr. Bruno Batinica, a Postdoctoral Associate at the Yale School of Medicine, explores how AI models could identify patterns in ECG and echocardiography that may help flag patients for further evaluation.

en

00:04:45

Advancing ATTR-CM Identification: Early Findings from...

Conference Coverage ·

2026/09/03

Guest: Bruno Batinica, MD Could multimodal AI help identify patients with transthyretin amyloid cardiomyopathy (ATTR-CM) who might otherwise go undiagnosed? Dr. Bruno Batinica, a Postdoctoral Associate at the Yale School of Medicine, joins us to share early findings from the TRACE-AI study, including AI-enabled model performance across diverse health systems, the potential value of combining modalities to improve positive predictive value, and next steps toward prospective deployment

en

00:05:15

A More Complete View of Cardiovascular Risk in Women

Conference Coverage ·

2026/08/31

Guest: Noel Bairey Merz, MD Cardiovascular risk in women can emerge well before older age, but traditional approaches to risk assessment may overlook sex-specific factors in patients under 65. Dr. Noel Bairey Merz joins us to share how tools such as the PREVENT score and coronary artery calcium scoring, along with obstetric history and female-dominant conditions, can help us identify elevated risk earlier. Dr. Bairey Merz is the Director of the Barbra Streisand Women’s Health Center,

en

00:03:30

Complication-Centric Diabetes Care: Addressing...

Conference Coverage ·

2026/08/27

Guest: Scott D. Isaacs, MD FACP, FACE For patients with diabetes, effective care requires more than just lowering A1C. Dr. Scott Isaacs joins us to discuss the importance of incorporating comorbidities into care and strategies for systematic screening and follow-up. He’s the Immediate Past President of the American Association of Clinical Endocrinology and an Associate Professor of Medicine at Emory University School of Medicine.

en

00:02:45

Hypertension in T2D: Understanding the AACE...

Conference Coverage ·

2026/08/25

Guest: Scott D. Isaacs, MD FACP, FACE For patients with type 2 diabetes, the latest American Association of Clinical Endocrinology (AACE) guidance supports tailoring hypertension treatment to individual risk profiles. Dr. Scott Isaacs joins us to review updated blood pressure targets, first-line therapies, and management considerations for patients at increased risk. He's the Immediate Past President of the AACE and an Associate Professor of Medicine at Emory University School

en

00:07:15

Advancing Bone Health: Key Insights from ISO 2026

Conference Coverage ·

2026/07/14

Host: Marshall Miller Guest: Ami R. Patel From fracture liaison services to menopause care, the 2026 Interdisciplinary Symposium on Osteoporosis (ISO) covered the latest advances and interdisciplinary strategies in bone health. Join Marshall Miller and Ami Patel, Vice President of Science and Education at the Bone Health and Osteoporosis Foundation, for a recap of this year's meeting.

en

00:05:00

Survodutide in Obesity: Insights from SYNCHRONIZE-1

Conference Coverage ·

2026/06/17

Guest: Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD New findings from the SYNCHRONIZE-1 trial reveal that survodutide's impact extends beyond weight reduction, with a demonstrated decrease in liver fat and meaningful improvements across multiple markers of metabolic health in patients without type 2 diabetes. Dr. Carel le Roux joins us to share the efficacy and safety data and explore what these results could mean for the future of metabolic disease management. Dr. Le Roux is the

en

00:05:00

Understanding Residual Cardiovascular Risk in CKD and...

Conference Coverage ·

2026/06/09

Guest: John W. Ostrominski, MD, MPH Despite advances in glycemic management, blood pressure control, lipid lowering, and disease-modifying therapies, patients with chronic kidney disease (CKD) and type 2 diabetes continue to face substantial residual cardiovascular risk. In this program, Dr. John Ostrominski reviews emerging evidence linking low-grade systemic inflammation to adverse cardiovascular outcomes in this high-risk population, highlighting findings from the FIDELITY pooled

en

00:04:30

Addressing Cost-Related Medication Non-Adherence in...

Conference Coverage ·

2026/06/09

Guest: Kimberly Narain, MD, MPH, PhD Cost-related medication nonadherence remains a significant but often hidden barrier to effective diabetes care, with out-of-pocket costs preventing patients from accessing essential therapies. Dr. Kimberly Narain joins us to explain why clinicians should look beyond insurance status alone and consider affordability challenges when developing strategies to improve diabetes outcomes. Dr. Narain is an Assistant Professor of Medicine at the David Geffen

en

00:13:15

Digital Innovation in Diabetes Prevention for Older...

Conference Coverage ·

2026/06/08

Host: Steve Jackson, PharmD Guest: Souptik Barua, PhD Guest: Emily Johnston, MPH, PhD Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Dr. Emily Johnston and Dr. Souptik Barua discuss emerging insights on how these strategies could improve accessibility and engagement in a high-risk population. Dr. Johnston is a Research Assistant Professor in the

en

All Episodes

Similar Podcasts

Ciência

RFI Português

天方烨谈

基因频道

Quilo de Ciencia - Cienciaes.com

Jorge Laborda

The Field Guides

The Field Guides

Down to Earth

FRANCE 24 English